Atossa Genetics, Inc.
Company Information

4105 E Madison St
Seattle, WA, 98112 United States
(206) 325-6086

Top 3 Competitors

Unlock access to all reports with a Hoover's Professional Subscription
Call (866) 473-3932 today to get
started with a FREE TRIAL!

  • Up-to-the moment intelligence helps you set strategy, prepare for sales calls, and close business.
  • Easy-to-read reports on over 85 million companies and 900 industries build your understanding of the companies you work with.
  • High-quality, reasonably-priced reports save you hours of costly research.

Unlock a Hoover's Basic Subscription.
To talk to a Business Information Consultant please call (866) 473-3932


Atossa Genetics, Inc. Company Profile

A development-stage company, Atossa Genetics owns and markets the MASCT (Mammary Aspirate Specimen Cytology Test) System, which was created by Atossa founder Steven Quay and tests for precursors to breast cancer. The MASCT System goes beyond mammograms in that it can detect genetic pre-cancerous conditions in the breast up to eight years before a mammography. Patented and approved by the FDA, the device is a handheld pump used to collect fluid from breast milk ducts in about 10 minutes. Atossa also offers related screening tests. The company filed an initial public offering (IPO) in 2010, but later withdrew the offering; it filed again in 2012.